Aerovate Therapeutics (AVTE) Earnings Date, Estimates & Call Transcripts → Here’s how to start a “Weekend Side Hustle” from your sofa (From DTI) (Ad) Free avte Stock Alerts $22.05 +0.45 (+2.08%) (As of 04/19/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAVTE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AVTE Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIThis company has increased its dividend every year for 54 yearsThere are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.Click here to get them (for Free). Aerovate Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($2.78) EPSNext Year EPS Consensus Estimate: ($2.90) EPSAVTE Earnings Date and InformationAerovate Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.Read More Get Aerovate Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for AVTE and its competitors with MarketBeat's FREE daily newsletter. Aerovate Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/20/2024Estimated)------- 11/13/2023Q3 2023($0.70)($0.71)($0.01)($0.71)--8/14/2023Q2 2023($0.69)($0.76)($0.07)($0.76)--5/15/2023Q1 2023($0.58)($0.67)($0.09)($0.67)--3/29/2023Q4 2022($0.58)($0.61)($0.03)($0.61)--11/14/2022Q3 2022($0.50)($0.56)($0.06)($0.56)--8/15/2022Q2 2022($0.46)($0.49)($0.03)($0.49)-- Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/16/2022Q1 2022($0.26)($0.45)($0.19)($0.45)--3/30/2022Q4 2021-($0.07)($0.07)($0.07)--11/14/2021Q3 2021($0.26)($0.26)-($0.26)--8/15/2021Q2 2021($0.16)($23.80)($23.64)($23.80)-- Aerovate Therapeutics Earnings - Frequently Asked Questions When is Aerovate Therapeutics's earnings date? Aerovate Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on AVTE's earnings history. How much profit does Aerovate Therapeutics generate each year? Aerovate Therapeutics (NASDAQ:AVTE) has a recorded net income of -$75.52 million. AVTE has generated -$2.88 earnings per share over the last four quarters. What is Aerovate Therapeutics's EPS forecast for next year? Aerovate Therapeutics's earnings are expected to decrease from ($2.78) per share to ($2.90) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Longboard Pharmaceuticals Earnings Bicycle Therapeutics Earnings Y-mAbs Therapeutics Earnings Pharming Group Earnings ORIC Pharmaceuticals Earnings Silence Therapeutics Earnings SIGA Technologies Earnings Zymeworks Earnings Praxis Precision Medicines Earnings Lyell Immunopharma Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NASDAQ:AVTE) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy SykesMy biggest AI fearParadigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.